InvestorsObserver
×
News Home

Premarket Mover: Reviva Pharmaceuticals Holdings, Inc. (RVPH) Up 9.23%

Thursday, March 28, 2024 06:55 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Reviva Pharmaceuticals Holdings, Inc. (RVPH) Up 9.23%

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has gained Thursday morning, with the stock adding 9.23% in pre-market trading to 4.26. RVPH's short-term technical score of 41 indicates that the stock has traded less bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 104 out of 146 industries, the stock ranks higher than 56% of stocks. Reviva Pharmaceuticals Holdings, Inc. has fallen 10.34% over the past month, closing at $3.81 on February 29. During this period of time, the stock fell as low as $2.76 and as high as $4.07. RVPH has an average analyst recommendation of Strong Buy. The company has an average price target of $18.25.

Overall Score - 47
RVPH has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on RVPH!
Reviva Pharmaceuticals Holdings, Inc. has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, RVPH ranks better than 69% of stocks.

Important Dates for Investors in RVPH:

-Reviva Pharmaceuticals Holdings, Inc. is set to release earnings on 2024-04-04. Over the last 12 months, the company has reported EPS of $-1.66. -We do not have a set dividend date for Reviva Pharmaceuticals Holdings, Inc. at this time. Click Here To Get The Full Report on Reviva Pharmaceuticals Holdings, Inc. (RVPH)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App